
Hosted by cgmEDUCATION.net · EN

Part 1: Speeding Ahead, But Still Catching Up: Ultra Rapid-Acting Insulins and Modes of Administration/Mechanisms of Action with Julia Blanchette, PhD, RN, BC-ADM, CDCES

Part 2: Inhaled Insulin in Pediatric Diabetes Results of the INHALE-1 Trial with Michael J. Haller, MD

Part 3: Clinical Discussion & Q&A with Julia Blanchette, PhD, RN, BC-ADM, CDCES and Michael J. Haller, MD

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD, MACP and Carol J. Levy, MD, CDCES.

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD and David T. Ahn, MD.

Zobair M. Younossi, MD, Christina Hanson, FNP, Diana Isaacs, PharmD, and Marcelo Kugelmas, MD, present Arresting MASLD/MASH-Related Fibrosis Progression & Sequelae in PwD T2 at AACE '25

Ultra Rapid-acting Insulins: Modes of Administration/Mechanisms of Action in RHIs/RAIs with Irl B. Hirsch, MD and Desmond A Schatz, MD.

MASLD/MASH in People with Diabetes: '24 Guidelines on Identification • Diagnosis • Management with Novel Therapies: presented by Carol H. Wysham, MD, FACP

Patient Perspectives: Grazia Aleppo, MD, FACE and her patient Michael (PwD) on Ultra Rapid-acting Insulins

Welcome & Housekeeping Introduction DTR X